This dose of captopril was previously shown to abolish approximately 95% of splenic ACE enzymatic activity in mice infected with Histoplasma capsulatum and is 30- to 50-fold higher than the maximum daily captopril dose used in treating cardiovascular disease in humans (54). This evidence concerns the gene ACE and cardiovascular disorder.